International Companies
Netcare CEO says Covid-19 cases in SA much milder so far
Symptoms among those ill from Covid-19 during the current wave caused by the new variant Omicron are far milder than in previous waves, the head of South Africa's largest private health-care group said.
Pfizer-BioNTech booster does neutralise Omicron, preliminary study shows
Three doses of the Covid-19 vaccine developed by Pfizer and BioNTech do neutralise the Omicron variant of Covid-19, the results of a preliminary study revealed.
Weibo shares fall on Hong Kong debut
Shares in Weibo fell on Wednesday as trading in the Chinese tech giant got underway in Hong Kong.
Profits hit record hight at commodity trader Trafigura
Global commodity trader Trafigura reported record results on Wednesday, including annual revenues of more than $231bn, as it benefited from soaring oil and gas prices.
Shares in Chinese developer Kaisa suspended
Trading in embattled developer Kaisa Group Holdings has been suspended, prompting fresh concerns about potential defaults across China’s debt-laden property sector.
Mimecast to go private as Permira snaps up stock in $80 per share deal
Email security and cyber resilience company Mimecast has entered a definitive agreement that will see the firm go private.
Medicago and GSK's Covid-19 vaccine shows 75.3% efficacy against Delta strain
Medicago and GSK's Covid-19 vaccine showed a high degree of efficacy in blocking symptomatic disease in those infected with the Delta strain of SARS-CoV-2.
Evergrande shares plummet on default fears
Shares in troubled property developer China Evergrande Group tumbled on Monday, as the hugely-indebted firm moved closer to a potential default.
Two Hutchmed drugs included in China's 2022 reimbursement list
Hutchmed China announced on Friday that, following negotiations with the China National Healthcare Security Administration (NHSA), from 1 January the updated National Reimbursement Drug List (NRDL) will continue to include ‘Elunate’, or fruquintinib, and would now include ‘Sulanda’, or surufatinib.
Didi planning to delist US shares in move to Hong Kong
China-based ride-hailing giant Didi Chuxing is planning to delist its shares from the New York Stock Exchange, it said on Friday, as part of a move to Hong Kong.
FTC takes legal action to block Nvidia's takeover of Arm
The US Federal Trade Commission has taken legal action to block chipmaker Nvidia's proposed $40. 0bn takeover of Cambridge-based chip designer Arm, citing competition concerns.
Weston family agrees £4bn sale of Selfridges Group
High-end department store chain Selfridges Group has sold for £4bn, it was reported on Thursday, to the privately-held Thailand conglomerate Central Group.
Apple warns suppliers of weakened iPhone demand
Tech giant Apple has warned component suppliers that demand for its flagship iPhone handset had weakened with the 13th iteration of its device.